Search Results

There are 12696 results for: content related to: Sleep and cognition at baseline and the effects of REM sleep diminution after 1 week of antidepressive treatment in patients with depression

  1. Behavior-dependent modulation of hippocampal EEG activity by the selective norepinephrine reuptake inhibitor reboxetine in rats

    Hippocampus

    Volume 17, Issue 8, August 2007, Pages: 627–633, Bernat Kocsis, Shaomin Li and Mihaly Hajos

    Article first published online : 9 MAY 2007, DOI: 10.1002/hipo.20299

  2. You have free access to this content
    Estimation of binding rate constants using a simultaneous mixed-effects method: application to monoamine transporter reuptake inhibitor reboxetine

    British Journal of Pharmacology

    Volume 160, Issue 2, May 2010, Pages: 389–398, Neil Benson, Nelleke Snelder, Bart Ploeger, Carolyn Napier, Harriet Sale, Nigel JM Birdsall, Richard P Butt and Piet H van der Graaf

    Article first published online : 3 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00719.x

  3. Lack of effect of reboxetine on cardiac repolarization

    Clinical Pharmacology & Therapeutics

    Volume 70, Issue 3, September 2001, Pages: 261–269, Joseph C. Fleishaker, Steven F. Francom, Beth D. Herman, Dean W. Knuth and Nkechi E. Azie

    Article first published online : 27 SEP 2001, DOI: 10.1067/mcp.2001.117705

  4. You have free access to this content
    The Selective Norepinephrine Reuptake Inhibitor Antidepressant Reboxetine: Pharmacological and Clinical Profile

    CNS Drug Reviews

    Volume 10, Issue 1, March 2004, Pages: 23–44, Mihály Hajós, Joseph C. Fleishaker, Jacqueline K. Filipiak-Reisner, Mark T. Brown and Erik H. F. Wong

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2004.tb00002.x

  5. Ketoconazole inhibits the clearance of the enantiomers of the antidepressant reboxetine in humans

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 4, October 1999, Pages: 374–379, Beth D. Herman, Joseph C. Fleishaker and Mark T. Brown

    Article first published online : 14 OCT 1999, DOI: 10.1053/cp.1999.v66.a101207

  6. You have free access to this content
    Abstracts of the ESRS, Prague 2004

    Journal of Sleep Research

    Volume 13, Issue s1, September 2004, Pages: 1–832,

    Article first published online : 1 OCT 2004, DOI: 10.1111/j.1365-2869.2004.00410.x

  7. The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 2, August 2011, Pages: 246–255, CM Hysek, LD Simmler, M Ineichen, E Grouzmann, MC Hoener, R Brenneisen, J Huwyler and ME Liechti

    Article first published online : 15 JUN 2011, DOI: 10.1038/clpt.2011.78

  8. You have free access to this content
    Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize α2-adrenoceptors in the prefrontal cortex

    British Journal of Pharmacology

    Volume 132, Issue 1, January 2001, Pages: 183–188, R W Invernizzi, S Parini, G Sacchetti, C Fracasso, S Caccia, K Annoni and R Samanin

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0703821

  9. Absolute bioavailability of reboxetine enantiomers and effect of gender on pharmacokinetics

    Biopharmaceutics & Drug Disposition

    Volume 20, Issue 1, January 1999, Pages: 53–57, Joseph C. Fleishaker, Massimiliano Mucci, Cinzia Pellizzoni and Italo Poggesi

    Article first published online : 14 APR 1999, DOI: 10.1002/(SICI)1099-081X(199901)20:1<53::AID-BDD157>3.0.CO;2-P

  10. You have free access to this content
    Paroxetine versus other anti-depressive agents for depression

    Intervention Review

    The Cochrane Library

    Marianna Purgato, Davide Papola, Chiara Gastaldon, Carlotta Trespidi, Laura R Magni, Carla Rizzo, Toshi A Furukawa, Norio Watanabe, Andrea Cipriani and Corrado Barbui

    Published Online : 3 APR 2014, DOI: 10.1002/14651858.CD006531.pub2

  11. Separation of reboxetine enantiomers by means of capillary electrophoresis

    ELECTROPHORESIS

    Volume 23, Issue 12, No. 12 June 2002, Pages: 1870–1877, Maria A. Raggi, Roberto Mandrioli, Cesare Sabbioni, Carlo Parenti, Giuseppe Cannazza and Salvatore Fanali

    Article first published online : 2 JUL 2002, DOI: 10.1002/1522-2683(200206)23:12<1870::AID-ELPS1870>3.0.CO;2-R

  12. Hemodynamic effects of reboxetine in healthy male volunteers

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 3, September 1999, Pages: 282–287, Thierry Denolle, Cinzia Pellizzoni, M. Gabriella Jannuzzo and Italo Poggesi

    Article first published online : 26 SEP 1999, DOI: 10.1016/S0009-9236(99)70036-6

  13. Reboxetine: tolerability and safety profile in patients with major depression

    Acta Psychiatrica Scandinavica

    Volume 101, Issue s402, June 2000, Pages: 37–40, Lars Tanum

    Article first published online : 22 OCT 2003, DOI: 10.1034/j.1600-0447.2000.02606.x

  14. You have free access to this content
    The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy

    Epilepsia

    Volume 53, Issue 5, May 2012, Pages: 870–878, Katia Vermoesen, Ann Massie, Ilse Smolders and Ralph Clinckers

    Article first published online : 16 MAR 2012, DOI: 10.1111/j.1528-1167.2012.03436.x

  15. Reboxetine, a selective noradrenaline reuptake inhibitor, is non-sedative and does not impair psychomotor performance in healthy subjects

    Human Psychopharmacology: Clinical and Experimental

    Volume 13, Issue 6, August 1998, Pages: 425–433, Werner M. Herrmann and Hermann Fuder

    Article first published online : 21 DEC 1998, DOI: 10.1002/(SICI)1099-1077(199808)13:6<425::AID-HUP17>3.0.CO;2-R

  16. The need for new and better antidepressants: reboxetine a new option

    Acta Psychiatrica Scandinavica

    Volume 101, Issue s402, June 2000, Pages: 6–11, Sven J. Dencker

    Article first published online : 22 OCT 2003, DOI: 10.1034/j.1600-0447.2000.02602.x

  17. You have free access to this content
    Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain

    British Journal of Pharmacology

    Volume 128, Issue 6, November 1999, Pages: 1332–1338, G Sacchetti, M Bernini, A Bianchetti, S Parini, R W Invernizzi and R Samanin

    Article first published online : 30 JAN 2009, DOI: 10.1038/sj.bjp.0702926

  18. Clinical efficacy of reboxetine: a comparative study with desipramine, with methodological considerations

    Human Psychopharmacology: Clinical and Experimental

    Volume 13, Issue S1, February 1998, Pages: S29–S39, T. A. Ban, P. Gaszner, E. Aguglia, R. Batista, A. Castillo, A. Lipcsey, J.-P. Macher, A. Torres-Ruiz and L. Vergara

    Article first published online : 21 DEC 1998, DOI: 10.1002/(SICI)1099-1077(199802)13:1+<S29::AID-HUP980>3.0.CO;2-D

  19. You have free access to this content
    The Promises and Pitfalls of Reboxetine

    CNS Drug Reviews

    Volume 9, Issue 4, December 2003, Pages: 327–342, Michelle E. Page

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2003.tb00258.x

  20. Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons

    European Journal of Neuroscience

    Volume 13, Issue 11, June 2001, Pages: 2077–2087, Steven T. Szabo and Pierre Blier

    Article first published online : 20 DEC 2001, DOI: 10.1046/j.0953-816x.2001.01583.x